On March 23, 2022, the FDA approved the therapeutic radiopharmaceutical agent Pluvicto™ (lutetium Lu 177 vipivotide tetraxetan, also known as 177Lu-PSMA-617) for treatment of metastatic prostate cancer detected on prostate-specific membrane antigen (PSMA) PET imaging....
The American Society of Clinical Oncology (ASCO) held its annual meeting June 3-7, 2022, in Chicago, Illinois, with the theme “Advancing Equitable Cancer Care Through Innovation.” Several thousand studies were presented at the first in-person meeting since 2019....
In March 2021, the U.S. Preventative Services Task Force (USPSTF) updated their guidelines for lung cancer screening with low-dose CT (LDCT).((Centers for Medicare & Medicaid Services. Screening for lung cancer with low dose computed tomography (LDCT) [Internet]....
Carelon has received several questions regarding upcoming codes for LiverMultiScan (LMS) – CPT 0648T/0649T and Cone-beam breast CT (CBCT) – CPT 0633T-0638T. Additional information and rationale is provided below to clarify how these codes will be managed. For...
On May 18th, 2021, the U.S. Preventive Services Task Force (USPSTF) issued a revised recommendation statement on screening for colorectal cancer. ((US Preventive Services Task Force. Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation...
A cross sectional study published in the JAMA Open Network in April 2021 examines U.S. population-based cancer statistics and census data to predict trends in cancer incidence and mortality over the next 20 years.((Estimated Projection of US Cancer Incidence and Death...
The FDA recently approved two new radiotracers for use in prostate cancer. Gallium (Ga)-68 prostate-specific membrane antigen (PSMA) was the first, approved in December of 2020. PSMA is a protein unique to prostate tissue which is found in high concentration in...
The DENSE trial (Dense Tissue and Early Breast Neoplasm Screening) is an ongoing study designed to help define the role of breast MRI in screening women with dense breast tissue. In an article published in the May issue of Radiology, the authors present findings from...
In January 2021, the U.S. Preventive Services Task Force (USPSTF) began the process of updating its recommendations for breast cancer screening. The announcement and call for public comment on the research plan are the initial steps in the update process. Once the...
The U.S. Preventive Services Task Force (USPSTF) issued a revised recommendation statement on screening for lung cancer on March 9th, 2021. (( US Preventive Services Task Force. Screening for lung cancer: US Preventive Services Task Force recommendation statement....